Maksymilian Świniarski

Maksymilian Świniarski is a seasoned executive in the pharmaceutical and healthcare sectors, currently serving as the Chief Executive Officer and General Manager of Polfa Tarchomin S.A. since June 2024, a historic pharmaceutical company established in 1823. Prior to this role, Maksymilian held leadership positions including Co-Owner at CHC PHARMA sp. z o.o. and General Manager for Rhei Life in Poland. Maksymilian's extensive experience includes significant roles at AstraZeneca and Eli Lilly, where responsibilities encompassed managing large teams and overseeing substantial sales portfolios in the diabetes care market. Educational qualifications include a Master of Science in Political Science from Vistula University and executive training at Harvard Business School.